Key result
Participation in cardiac rehabilitation was associated with a significantly higher likelihood of smoking cessation (OR 2.42) and acceptable glucose control (OR 1.70) compared to non-participation.
Why the study?
While cardiac rehabilitation improves survival outcomes in ischemic heart disease, the long-term benefits of short-term programs are still debated.
Does cardiac rehabilitation improve risk factor management and quality of life in patients with ischemic heart disease?
Population
1012 patients aged 80 years or younger hospitalized for ACS or myocardial revascularization
Comparison
Cardiac rehabilitation participation vs no participation
Design
Multicenter cross-sectional registry study with propensity score matching
Follow-up
6 to 18 months
Authors
Loading...
CR participation linked to better smoking cessation, glycemic control, and QoL; leaves open whether sustained programs are needed to maintain benefits.
Cross-Sectional (n=1,012)
Yes
Does cardiac rehabilitation improve risk factor management and quality of life in patients with ischemic heart disease?
Odds Ratio: 2.42 (95% CI 1.33–4.14)
Absolute Event Rate: 54.4% vs 33%
p-value: p=<0.001
Cardiac rehabilitation is moderately effective at improving smoking cessation, glucose control, and quality of life in patients with ischemic heart disease, highlighting the need for long-term support strategies.
Sinnadurai et al. (2021) conducted a cross-sectional in ischemic heart disease (n=1,012). Cardiac rehabilitation vs. No cardiac rehabilitation was evaluated on Smoking cessation (OR 2.42, 95% CI 1.33-4.14, p=<0.001). Participation in cardiac rehabilitation was associated with a significantly higher likelihood of smoking cessation (OR 2.42) and acceptable glucose control (OR 1.70) compared to non-participation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: